#16
|
||||
|
||||
Öèòàòà:
|
#17
|
||||
|
||||
Ïîêà ýòî âñå ïðåäïîëîæåíèÿ â ñòèëå "çà è ïðîòèâ", à ðåçóëüòàòû êëèí. èññëåäîâàíèé îòâåòÿò íà âîïðîñ èìååò ñìûñë â èõ èñïîëüçîâàíèè èëè íåò.
Âîò êàíàäåö Ðåéä àêòèâíî ïðîìîöèðóåò çíà÷èìîñòü ñâîèõ ðàáîò: Urogenital infections in women: can probiotics help? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] È ïîêà åñòü íåêîòîðûå êëèí. óñïåõè ó íåãî: 40 women diagnosed with BV by discharge, fishy odor, sialidase positive test and Nugent Gram stain scoring, were randomized to receive either two dried capsules containing Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 each night for 5 days, or 0.75% metronidazole gel, applied vaginally twice a day (in the morning and evening). Follow-up at day 6, 15 and 30 showed cure of BV in significantly more probiotic treated subjects (16, 17 and 18/20, respectively) compared to metronidazole treatment (9, 9 and 11/20: P = 0.016 at day 6, P = 0.002 at day 15 and P = 0.056 at day 30). This is the first report of an effective (90%) cure of BV using probiotic lactobacilli... The probiotic treatment was even more effective than metronidazole vaginal gel, for reasons not investigated in this study. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 2006 Oct;8(12-13):2772-6. Ñ 2005 ã â Êàíàäå èäåò èññëåäîâàíèå ïî ýòèì ïðèáèîòèêàì äëÿ ïðîôèëàêòèêè ïðåæäåâðåìåííûõ ðîäîâ: Effect of Probiotic Lactobacilli on Vaginal Flora of Pregnant Women at High Risk for Preterm Delivery Further study details as provided by Mount Sinai Hospital, Canada Primary Outcome Measures: Determination if restoration of a normal vaginal flora through the use of probiotics reduces the incidence of PTB. Total Enrollment: 160, Study start: February 2005  Ñèýòòëå èäåò NCT00305227 The purpose of this study is to evaluate the safety of LACTIN-V (Lactobacillus crispatus CTV-05) and to see whether it is an effective method of preventing recurrent urinary tract infections (UTI's). LACTIN-V is a vaginal suppository that contains Lactobacillus crispatus, an organism found naturally in the vaginas of healthy women. Lactobacillus bacteria are thought to prevent other bacteria such as E. coli from causing UTI's. Íàâåðíîå, òåîðåòè÷åñêîãî áàçèñà èì äîñòàòî÷íî, ÷òî áû òåñòèðîâàòü â êàêîé êëèí. ðåçóëüòàò ýòî âûëüåòñÿ? ÏÑ. Ñèòóàöèÿ íåìíîãî íàïîìèíàåò î äåáàòàõ 10-15 ëåòíåé äàâíîñòè ïî êëþêâåííîìó ñîêó â ïðîôèëàêòèêå èíôåêöèé ìî÷åâûâîäÿùèõ ïóòåé, ïîêà íå ïðîâåëè ñîîòâ. ÐÊÈ è íå äîêàçàëè ñ ïîçèöèé ÅÁÌ, ÷òî óæå ïîïàëî â Êîêðýéíîâñêóþ áàçó: Cochrane Database Syst Rev. 2004;(2):CD001321 È ïî áîëüøîìó ñ÷åòó âñå ðàâíî: îêàçûâàåò ëè êàêîå àíòèáàêòåðèàëüíîå äåéñòâèå ýòîò ýêñòðàêò èëè æå òîëüêî ïðåïÿòñòâóåò ïðèöåïëåíèþ áàêòåðèé ê óðîýïèòåëèþ.
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#18
|
||||
|
||||
Öèòàòà:
Öèòàòà:
Âû æå ñàìè óòâåðæäàåò, ÷òî Öèòàòà:
Öèòàòà:
Ëè÷íî ÿ íå õî÷ó ýêñïåðåìåíòèðîâàòü íà ñâîèõ ïàöèåíòàõ, ïîòîìó êàê íå èìåþ äîñòàòî÷íîé óâåðåííîñòè, ÷òî èñïîëüçóÿ äàííóþ ìåòîäèêó, íå íàíåñó âðåä. Êàæäûé îòâå÷àåò è ðåøàåò çà ñåáÿ. |
#19
|
||||
|
||||
Öèòàòà:
|
#20
|
|||
|
|||
Öèòàòà:
Òóò óæ ïðèäåòñÿ îáðàùàòü âíèìàíèå è íà ãîðìîíàëüíóþ ñèñòåìó, è íà íåðâíóþ ñèñòåìó, è íà ñîñòîÿíèå ÆÊÒ, íà êà÷åñòâåííûé è êîëè÷åñòâåííûé ñîñòàâ ïèòàíèÿ, è íà îñîáåííîñòè ëè÷íîé ãèãèåíû, è äàæå íà îñîáåííîñòè ïîëîâîé æèçíè è ò.ä Ïðîòîêîëû è ñòàíäàðòû ëå÷åíèÿ ýòî î÷åíü õîðîøî, íî ìåñòî äëÿ ëè÷íîñòíîãî ïîäõîäà ê ïàöèåíòó äîëæíî îñòàâàòüñÿ. Òåì áîëåå, ÷òî è àðñåíàë ëå÷åáíûõ ñðåäñòâ, íå èñ÷åðïûâàåòñÿ îäíèìè ñèíòåòè÷åñêèìè ôàðì.ïðåïàðàòàìè. |
#21
|
|||
|
|||
Öèòàòà:
Çàòî íàïèñàíî òàêîå: Several studies have evaluated the clinical and microbiologic efficacy of using lactobacillus intravaginal suppositories to restore normal flora and treat BV. However, no currently available lactobacillus suppository was determined to be better than placebo 1 month after therapy for either clinical or microbiologic cure. No data support the use of douching for treatment or relief of symptoms. |